Pacira BioSciences (PCRX) Gross Profit (2010 - 2026)
Pacira BioSciences (PCRX) reported Gross Profit of $148.24 million for Q2 2026, up 5.7% from $140.23 million a year earlier and up 5.2% from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) Gross Profit (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Pacira BioSciences' Gross Profit came in at $591.01 million, up 7.1% year-over-year; for FY2025, it was $576.66 million, up 8.7% from FY2024.
- Gross Profit has increased for five consecutive years, with a five-year compound annual growth rate of 13.0% (FY2020 to FY2025).
- By year, Gross Profit came in at $530.54 million in FY2024 (+8.2%), $490.31 million in FY2023 (+4.9%), $467.53 million in FY2022 (+16.5%) and $401.28 million in FY2021 (+28.5%).
- Five-year quarterly Gross Profit spans a low of $93.07 million in Q3 2021 and a high of $156.57 million in Q4 2025.
- Year over year, Gross Profit has now increased in each of the last 13 quarters, with growth averaging 7.6% over the last eight quarters.
- The high point for year-over-year Gross Profit in five years was Q1 2022 (growth of 39.1%); the low point was Q1 2023 (a decline of 8.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $140.96 million (Q1 2026), $156.57 million (Q4 2025) and $145.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Pacira BioSciences | 1.46 Bn | 468.61 Mn | 139.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 139.42 Mn |
| Jun 30, 2026 | 148.24 Mn |
| Mar 31, 2026 | 140.96 Mn |
| Dec 31, 2025 | 156.57 Mn |
| Sep 30, 2025 | 145.24 Mn |
| Jun 30, 2025 | 140.23 Mn |
| Mar 31, 2025 | 134.62 Mn |
| Dec 31, 2024 | 147.37 Mn |
| Sep 30, 2024 | 129.71 Mn |
| Jun 30, 2024 | 133.76 Mn |
| Mar 31, 2024 | 119.70 Mn |
| Dec 31, 2023 | 133.55 Mn |
| Sep 30, 2023 | 124.18 Mn |
| Jun 30, 2023 | 121.26 Mn |
| Mar 31, 2023 | 111.32 Mn |
| Dec 31, 2022 | 110.04 Mn |
| Sep 30, 2022 | 116.79 Mn |
| Jun 30, 2022 | 118.78 Mn |
| Mar 31, 2022 | 121.92 Mn |
| Dec 31, 2021 | 120.19 Mn |
API Access
Pacira BioSciences Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();